The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
|Articles|August 17, 2006
Long-Cycle, Low-Dosage HRT Using Esterified Estrogens
Author(s)Bruce Ettinger, MD
From ACOG - Philadelphia, Pennsylvania - May, 1999
Advertisement
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of RealPlayer, available
Advertisement
Related to this article
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.
Before prescribing testosterone, know what the evidence actually proves. Maria Uloko, MD, draws a sharp line between the one population the data supports and the much wider group of women asking about it.
"Although availability of certain products or brands may vary by pharmacy or location, estradiol transdermal patches remain available," stated the federal agency in an update.
A recap of the top stories from August 2026 in women's health.
Take a look back at some of the top FDA and pipeline news in women's health from August 2026.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Pellet therapy and practical advice for hesitant prescribers
2
Reviewing the evidence about testosterone in women
3
FDA accepts extended duration sNDA for MIUDELLA IUD
4
SMFM: Managing high-risk pregnancies amid abortion care restrictions
5